Hansa Biopharma AB (HNSBF)
3.70
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Hansa Biopharma Net Income (Quarterly) : -27.82M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.82M |
| March 31, 2026 | -21.48M |
| December 31, 2025 | -17.54M |
| September 30, 2025 | -15.58M |
| June 30, 2025 | -20.38M |
| March 31, 2025 | -3.640M |
| December 31, 2024 | -25.64M |
| September 30, 2024 | -9.959M |
| June 30, 2024 | -19.45M |
| March 31, 2024 | -21.03M |
| December 31, 2023 | -11.67M |
| September 30, 2023 | -23.18M |
| June 30, 2023 | -23.83M |
| March 31, 2023 | -19.68M |
| December 31, 2022 | -13.72M |
| September 30, 2022 | -14.59M |
| June 30, 2022 | -17.27M |
| March 31, 2022 | -14.82M |
| December 31, 2021 | -18.44M |
| September 30, 2021 | -17.16M |
| June 30, 2021 | -15.76M |
| March 31, 2021 | -12.37M |
| December 31, 2020 | -12.29M |
| Date | Value |
|---|---|
| September 30, 2020 | -13.80M |
| June 30, 2020 | -10.26M |
| March 31, 2020 | -9.644M |
| December 31, 2019 | -11.53M |
| September 30, 2019 | -9.830M |
| June 30, 2019 | -8.722M |
| March 31, 2019 | -7.899M |
| December 31, 2018 | -8.981M |
| September 30, 2018 | -6.869M |
| June 30, 2018 | -6.773M |
| March 31, 2018 | -5.731M |
| December 31, 2017 | -5.888M |
| September 30, 2017 | -4.611M |
| June 30, 2017 | -5.132M |
| March 31, 2017 | -5.044M |
| December 31, 2016 | -3.706M |
| September 30, 2016 | -3.160M |
| June 30, 2016 | -3.734M |
| March 31, 2016 | -2.361M |
| December 31, 2015 | -2.248M |
| September 30, 2015 | -1.642M |
| June 30, 2015 | -2.675M |
| March 31, 2015 | -1.286M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| BioArctic AB | -1.193M |
| Swedish Orphan Biovitrum AB | 117.25M |
| Diamyd Medical AB | -13.67M |
| BONESUPPORT HOLDING AB | 8.743M |
| BioInvent International AB | -13.12M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 5.136M |
| Total Expenses (Quarterly) | 32.96M |
| EPS Diluted (Quarterly) | -0.279 |
| Enterprise Value | 418.71M |
| Gross Profit Margin (Quarterly) | 53.57% |
| Profit Margin (Quarterly) | -541.7% |
| Earnings Yield | -22.87% |
| Normalized Earnings Yield | -22.25 |